Atara biotherapeutics announces appointment of cell & gene therapy expert maria grazia roncarolo, md to board of directors

Atara biotherapeutics, inc. (nasdaq: atra), a pioneer in t-cell immunotherapy leveraging its novel allogeneic ebv t-cell platform to develop transform

ATRA Ratings Summary

ATRA Quant Ranking